• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Double-digit growth seen in prescription inserts

Article

Des Plaines, IL—Addition Technology Inc. has seen another boost in sales of its micro-thin prescription inserts (Intacs).

Des Plaines, IL-Addition Technology Inc. has seen another boost in sales of its micro-thin prescription inserts (Intacs).

The company said its second-quarter 2005 sales of the prescription inserts, which are used to treat keratoconus and myopia, increased 55% versus the same quarter the previous year. Sales increased 45% over the first quarter this year. The company said it is the ninth consecutive quarter for double-digit growth.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
© 2024 MJH Life Sciences

All rights reserved.